214 related articles for article (PubMed ID: 17643635)
1. External application of rapamycin-eluting film at anastomotic sites inhibits neointimal hyperplasia in a canine model.
Kawatsu S; Oda K; Saiki Y; Tabata Y; Tabayashi K
Ann Thorac Surg; 2007 Aug; 84(2):560-7; discussion 567. PubMed ID: 17643635
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin-coated expanded polytetrafluoroethylene bypass grafts exhibit decreased anastomotic neointimal hyperplasia in a porcine model.
Cagiannos C; Abul-Khoudoud OR; DeRijk W; Shell DH; Jennings LK; Tolley EA; Handorf CR; Fabian TC
J Vasc Surg; 2005 Nov; 42(5):980-8. PubMed ID: 16275457
[TBL] [Abstract][Full Text] [Related]
3. Local application of rapamycin inhibits neointimal hyperplasia in experimental vein grafts.
Schachner T; Zou Y; Oberhuber A; Tzankov A; Mairinger T; Laufer G; Bonatti JO
Ann Thorac Surg; 2004 May; 77(5):1580-5. PubMed ID: 15111146
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model.
Lin PH; Bush RL; Yao Q; Lumsden AB; Chen C
J Surg Res; 2004 May; 118(1):45-52. PubMed ID: 15093716
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of neointimal hyperplasia in a sheep model of dialysis access failure with the bioabsorbable Vascular Wrap paclitaxel-eluting mesh.
Kohler TR; Toleikis PM; Gravett DM; Avelar RL
J Vasc Surg; 2007 May; 45(5):1029-1037; discussion 1037-8. PubMed ID: 17466798
[TBL] [Abstract][Full Text] [Related]
6. [Local applied slow-releasing rapamycin inhibits neointima hyperplasia in vein graft].
Zhang LF; Xiao F; Li J; Wang J; Shi ZH; Li CY
Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1706-9. PubMed ID: 16854327
[TBL] [Abstract][Full Text] [Related]
7. A novel biodegradable external mesh stent improved long-term patency of vein grafts by inhibiting intimal-medial hyperplasia in an experimental canine model.
Sato A; Kawamoto S; Watanabe M; Suzuki Y; Takahashi G; Masaki N; Kumagai K; Saijo Y; Tabayashi K; Saiki Y
Gen Thorac Cardiovasc Surg; 2016 Jan; 64(1):1-9. PubMed ID: 26419247
[TBL] [Abstract][Full Text] [Related]
8. Periadventitial rapamycin-eluting microbeads promote vein graft disease in long-term pig vein-into-artery interposition grafts.
Rajathurai T; Rizvi SI; Lin H; Angelini GD; Newby AC; Murphy GJ
Circ Cardiovasc Interv; 2010 Apr; 3(2):157-65. PubMed ID: 20332383
[TBL] [Abstract][Full Text] [Related]
9. Non-penetrating vascular clips anastomosis inhibited intimal thickening under poor runoff conditions in canine autogenous vein grafts.
Komori K; Shoji T; Furuyama T; Yonemitsu Y; Mori E; Yamaoka T; Matsumoto T; Sugimachi K
Eur J Vasc Endovasc Surg; 2001 Mar; 21(3):241-7. PubMed ID: 11352683
[TBL] [Abstract][Full Text] [Related]
10. [The pilot study of the effect of paclitaxel by local slow delivery on intimal hyperplasia of vascular anastomosis after vascular graft bypass].
Yuan L; Zhang XM; Li YK; Li QL; Zhao KQ; Sun KK; Xie DH; Zhang T
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3056-9. PubMed ID: 18261351
[TBL] [Abstract][Full Text] [Related]
11. Rapamycin treatment is associated with an increased apoptosis rate in experimental vein grafts.
Schachner T; Oberhuber A; Zou Y; Tzankov A; Ott H; Laufer G; Bonatti J
Eur J Cardiothorac Surg; 2005 Feb; 27(2):302-6. PubMed ID: 15691686
[TBL] [Abstract][Full Text] [Related]
12. Everolimus attenuates neointimal hyperplasia in cultured human saphenous vein grafts.
Semsroth S; Stigler RG; Bernecker OY; Ruttmann-Ulmer E; Troppmair J; Macfelda K; Bonatti JO; Laufer G
Eur J Cardiothorac Surg; 2009 Mar; 35(3):515-20. PubMed ID: 19167904
[TBL] [Abstract][Full Text] [Related]
13. [Perivenous support with autologous pericardium inhibits neointimal thickening in canine vein grafts].
Yang HW; Wu RB; Guo HM; Zheng SY
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jul; 26(7):1006-8. PubMed ID: 16864099
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of intimal proliferation after vein grafting by chitosan nanoparticle with proliferation cell nuclear antigen-antisense oligo deoxy nucleotides].
Chen Z; Zhang H; Xia J
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2007 Dec; 21(12):1348-54. PubMed ID: 18277682
[TBL] [Abstract][Full Text] [Related]
15. E2F decoy oligodeoxynucleotides on neointimal hyperplasia in canine vein graft.
Cho WH; Lee SO; Kim HT; Ahn JD; Lee IK
Transplant Proc; 2005; 37(1):77-9. PubMed ID: 15808553
[TBL] [Abstract][Full Text] [Related]
16. Prevention of intimal hyperplasia by single-dose pre-insertion external radiation in canine-vein interposition grafts.
Ulus AT; Tütün U; Zorlu F; Can C; Apaydin N; Karacagil S; Katircioğlu SF; Bayazit M
Eur J Vasc Endovasc Surg; 2000 May; 19(5):456-60. PubMed ID: 10828224
[TBL] [Abstract][Full Text] [Related]
17. Neointimal hyperplasia rapidly reaches steady state in a novel murine vein graft model.
Zhang L; Hagen PO; Kisslo J; Peppel K; Freedman NJ
J Vasc Surg; 2002 Oct; 36(4):824-32. PubMed ID: 12368745
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated expanded polytetrafluoroethylene haemodialysis grafts inhibit neointimal hyperplasia in porcine model of graft stenosis.
Lee BH; Nam HY; Kwon T; Kim SJ; Kwon GY; Jeon HJ; Lim HJ; Lee WK; Park JS; Ko JY; Kim DJ
Nephrol Dial Transplant; 2006 Sep; 21(9):2432-8. PubMed ID: 16554328
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts.
Chen C; Ofenloch JC; Yianni YP; Hanson SR; Lumsden AB
J Surg Res; 1998 Jul; 77(2):119-25. PubMed ID: 9733597
[TBL] [Abstract][Full Text] [Related]
20. The endothelin 1A receptor antagonist BSF 302146 is a potent inhibitor of neointimal and medial thickening in porcine saphenous vein-carotid artery interposition grafts.
Wan S; Yim AP; Johnson JL; Shukla N; Angelini GD; Smith FC; Dashwood MR; Jeremy JY
J Thorac Cardiovasc Surg; 2004 May; 127(5):1317-22. PubMed ID: 15115988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
